- Trials with a EudraCT protocol (12,700)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1,156)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Clinical Study on the Efficacy and Tolerability of Acarbose (BAY g 5421) Compared with Placeboin Diabetic Children on Conventional Insulin Treatment, in Particular with Observation of the Glycemic Control Index ( PH-24820 ) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0665_study_synopsis.pdf |
| View full study record |
| Document reference: 46158 |
| Study title: Clinical Study to Investigate the Efficacy and Tolerability of Acarbose (BAY g 5421) Versus Placebo in Diabetic Children (PH 23433) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0634_study_synopsis.pdf |
| View full study record |
| Document reference: 46155 |
| Study title: Double-Blind, Cross-Over Clinical Study at a Single Centre to Compare Acarbose (BAY g 5421) with Placebo in Respect of Efficacy and Tolerability in Patients with Cystic Fibrosis and Pathological Glucose Tolerance (Pilot Study)(PH-26068) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0696_study_synopsis.pdf |
| View full study record |
| Document reference: 46159 |
| Study title: NON RANDOMISED FOLLW-UP STUDY WITH ACARBOSE-TREATMENT AND PRE- AND AFTER-TREATMENT WITH PLACEBO IN DIABETIC CHILDREN (TYPE I) STUDY 0428 (PH 14352) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0428_study_synopsis.pdf |
| View full study record |
| Document reference: 46156 |
| Study title: TREATMENT OF CHICKENPOX IN CHILDREN WITH ZOVIRAX SUSPENSION IN A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL |
| Active substance: ACICLOVIR |
| Study summary document link (including results): Study ZOVIRAX- 183 Aciclovir Oral.xls |
| View full study record |
| Document reference: 46214 |
| Study title: A double-blind, multicenter, multi-dose, parallel group, placebo-controlled study on the efficacy and safety of a homeopathic combination remedy vs.placebo over 14 days of treatment in children with acute otitis media. |
| Active substance: Aconitum napellus Dil. D6 0,075 ml; Capsicum annuum Dil. D4 0,075 ml; Chamomilla recutita Ø 0,225 ml; Echinacea purpurea Ø 0,75 ml; Hydrargyrum bicyanatum Dil. D6 0,075 ml; Hydrastis canadensis Dil. D4 0,075 ml; Iodum Dil. D4 0,075 ml; Natrium tetraboracicum Dil. D4 0,075 ml; Sambucus nigra Ø 0,225 ml; Sanguinaria canadensis Ø 0,075 ml. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39772 |
| Study title: A double-blind, 2 period, cross-over, placebo-controlled study evaluating three daily doses of 4mg BW825C. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): Study BW825C31UK-Acrivastine.xls |
| View full study record |
| Document reference: 46909 |
| Study title: Gibbs−T−G, McDonnell−K−A, Stokes−T, Graham−A−A. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. The British journal of clinical practice, {Br−J−Clin−Pract}, Jan 1989, vol. 43, no. 1, p. 11−4.Gibbs−T−G, McDonnell−K−A, Stokes−T, Graham−A−A. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. The British journal of clinical practice, {Br−J−Clin−Pract}, Jan 1989, vol. 43, no. 1, p. 11−4. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46224 |
| Study title: Juhlin−L, Gibson−J−R, Harvey−S−G, Huson−L−W. Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double−blind, placebo−controlled study. International journal of dermatology, {Int−J−Dermatol}, Dec 1987, vol. 26, no. 10, p. 653−4.Juhlin−L, Gibson−J−R, Harvey−S−G, Huson−L−W. Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double−blind, placebo−controlled study. International journal of dermatology, {Int−J−Dermatol}, Dec 1987, vol. 26, no. 10, p. 653−4. |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46225 |
| Study title: Medical report of a double-blind, placebo-controlled, crossover study, to evaluate the efficacy and safety of 3 daily doses of 4 mg BW825C in children (6-13 yrs) exhibiting the symptoms of perennial allergic rhinitis, conducted by Dr. E.G. Weinberg, Cape Town, South Africa. Report No. BRAH/85/0011/00 |
| Active substance: ACRIVASTIN |
| Study summary document link (including results): Study H40-082-C86-Acrivastine.xls |
| View full study record |
| Document reference: 46227 |
| Study title: clinical study in the report N° FILIRF-FRZ0069-EN-E01: Comparison of oral lysine acetylsalicylate (Aspégic 500 ®) and a buffered aspirin (Bufferin ®) versus placebo for the relief of postoperative pain (3rd molar removal) - JF. Tecucianu, G. Bathelet, G. Narbonne - 1985 |
| Active substance: ACETYL SALICYLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46180 |
| Study title: Gibbs−T−G, McDonnell−K−A, Stokes−T, Graham−A−A. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. The British journal of clinical practice, {Br−J−Clin−Pract}, Jan 1989, vol. 43, no. 1, p. 11−4.Gibbs−T−G, McDonnell−K−A, Stokes−T, Graham−A−A. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. The British journal of clinical practice, {Br−J−Clin−Pract}, Jan 1989, vol. 43, no. 1, p. 11−4. |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46233 |
| Study title: Juhlin−L, Gibson−J−R, Harvey−S−G, Huson−L−W. Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double−blind, placebo−controlled study. International journal of dermatology, {Int−J−Dermatol}, Dec 1987, vol. 26, no. 10, p. 653−4.Juhlin−L, Gibson−J−R, Harvey−S−G, Huson−L−W. Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double−blind, placebo−controlled study. International journal of dermatology, {Int−J−Dermatol}, Dec 1987, vol. 26, no. 10, p. 653−4. |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46234 |
| Study title: Latte J et al. A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza. Clin Exp Pharmacol Physiol 2004; 31(7): 429-32Latte J et al. A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza. Clin Exp Pharmacol Physiol 2004; 31(7): 429-32 |
| Active substance: ACRIVASTIN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25809 |
| Study title: A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, and placebo in febrile children. Stat Rpt 32. Protocol 9-106, Unpublished Report 136. |
| Active substance: ACETYL SALICYLIC ACID AND PARACETAMOL |
| Study summary document link (including results): acetylsalicylic acid_paracetamol 9-106.pdf |
| View full study record |
| Document reference: 47203 |
| Study title: A phase IV double-blind single dose evaluation of the safety and efficacy of acetaminophen 1000 mg, aspirin 650 mg, and placebo in the treatment of pain following oral surgery. |
| Active substance: ACETYL SALICYLIC ACID AND PARACETAMOL |
| Study summary document link (including results): acetylsalicylic acid_paracetamol 2-231.pdf |
| View full study record |
| Document reference: 47205 |
| Study title: A phase IV double-blind single dose study of the efficacy and safety of acetaminophen 1000 mg, aspirin 1000 mg, and placebo in the treatment of pain following oral surgery. Stat Rpt 45. Protocol 3-251, Unpublished Report 157. |
| Active substance: ACETYL SALICYLIC ACID AND PARACETAMOL |
| Study summary document link (including results): acetylsalicylic acid_paracetamol 3-251.pdf |
| View full study record |
| Document reference: 47204 |
| Study title: A phase IV double-blind single dose study of the safety and efficacy of acetaminophen 1000 mg, Gemnisyn® 1300 mg, and placebo in the treatment of pain following oral surgery. |
| Active substance: ACETYL SALICYLIC ACID AND PARACETAMOL |
| Study summary document link (including results): acetylsalicylic acid_paracetamol 1-220.pdf |
| View full study record |
| Document reference: 47207 |
| Study title: Phase IV Double-Blind Single Dose Study of the Safety and Efficacy of Acetaminophen 1000 mg, Aspirin 650 mg, and Placebo in the Treatment of Pain Following Oral Surgery. |
| Active substance: ACETYL SALICYLIC ACID AND PARACETAMOL |
| Study summary document link (including results): acetylsalicylic acid_paracetamol 1-229.pdf |
| View full study record |
| Document reference: 47206 |
| Study title: phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, choline salicylate and placebo in febrile children. |
| Active substance: ACETYL SALICYLIC ACID AND PARACETAMOL AND CHOLINE SALICYLATE |
| Study summary document link (including results): acetylsalicylic acid_choline salicylate_paracetamol 118.pdf |
| View full study record |
| Document reference: 47208 |
